ORGANON & CO.

Lobbying for ORGANON & CO.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $320,000.00 expenses · posted Jul 20, 2026

Lobbying activity 2

Medicare/Medicaid

Drug pricing Women's health Biosimilars One Big Beautiful Bill Act (Public Law 119-21)--provisions related to Medicaid coverage, rural health funding, and drug pricing.

Budget/Appropriations

FY27 appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.